Bioenergetics & Carb MetabolismApril 18, 20265 min read

Q-Bank Breakdown: Pentose phosphate pathway — Why Every Answer Choice Matters

Clinical vignette on Pentose phosphate pathway. Explain correct answer, then systematically address each distractor. Tag: Biochemistry > Bioenergetics & Carb Metabolism.

You just opened a Q-bank question that looks like “PPP = NADPH + ribose,” and you’re tempted to pick the first familiar option and move on. Don’t. The pentose phosphate pathway (PPP) is a favorite testing ground because it quietly connects RBC survival, oxidative stress, fatty acid synthesis, and nucleotide production—and the distractors often test whether you actually understand those links.

Tag: Biochemistry > Bioenergetics & Carb Metabolism


The Clinical Vignette (Classic Step Style)

A 24-year-old man develops fatigue, jaundice, and dark urine 2 days after starting trimethoprim-sulfamethoxazole for a skin infection. He has scleral icterus. Labs show anemia with elevated LDH and indirect bilirubin. Peripheral smear shows bite cells and Heinz bodies.

Question: The patient’s condition is most directly due to decreased ability to generate which of the following?

A. NADH in the cytosol
B. NADPH in the cytosol
C. ATP in mitochondria via oxidative phosphorylation
D. Ribose-5-phosphate in the nucleus
E. UDP-glucuronic acid in hepatocytes


Step 1: Identify the Diagnosis Before You Touch the Answer Choices

This is G6PD deficiency → oxidative stress (sulfa drugs, dapsone, primaquine, nitrofurantoin, fava beans, infections) → hemolysis.

Key clues:

  • Heinz bodies = denatured hemoglobin (oxidative damage)
  • Bite cells = splenic macrophages “bite out” Heinz bodies
  • Hemolysis labs: ↑ LDH, ↑ indirect bilirubin, ↓ haptoglobin (often)

Core mechanism: RBCs rely on the PPP to make NADPH, which keeps glutathione reduced to detoxify reactive oxygen species.


Correct Answer: B. NADPH in the cytosol

Why NADPH is the linchpin (especially in RBCs)

RBCs have no mitochondria, so their antioxidant defenses heavily depend on cytosolic pathways.

PPP (oxidative phase) produces:

  • NADPH
  • Ribulose-5-phosphate (→ ribose-5-phosphate)

NADPH is required for:

  • Regenerating reduced glutathione (GSH) via glutathione reductase
  • Allowing glutathione peroxidase to neutralize H2O2H_2O_2 and other ROS

High-yield redox relationship:

  • Glutathione reductase: uses NADPH to convert oxidized glutathione (GSSG) → GSH
  • Glutathione peroxidase: uses GSH to reduce H2O2H_2O_2H2OH_2O

If NADPH is low → GSH can’t be regenerated → oxidative damage to hemoglobin → Heinz bodies → hemolysis.

The rate-limiting enzyme you should name on command

Glucose-6-phosphate dehydrogenase (G6PD)

  • Rate-limiting step of PPP oxidative phase
  • Converts glucose-6-phosphate → 6-phosphogluconolactone
  • Generates NADPH

The Pathway You’re Really Being Tested On (PPP in 60 seconds)

Oxidative phase (irreversible)

  • Makes 2 NADPH per glucose-6-phosphate
  • Produces ribulose-5-phosphate
  • Controlled by NADP+ availability (high NADP+ pushes PPP forward)

Non-oxidative phase (reversible)

  • Interconverts sugars via transketolase (TPP/B1) and transaldolase
  • Links PPP to glycolysis intermediates (fructose-6-phosphate, glyceraldehyde-3-phosphate)
  • Useful for making ribose-5-phosphate even when NADPH demand is low (and vice versa)

Now the Real Skill: Why Each Distractor Is Wrong (and What It Was Testing)

A. NADH in the cytosol

Why it’s tempting: Cytosolic NADH shows up in glycolysis (GAPDH step) and is tied to energy production.

Why it’s wrong here: The vignette is about oxidative damage in RBCs, where the protective currency is NADPH, not NADH.

High-yield contrast:

  • NADH: primarily for ATP generation (electron transport chain) and certain cytosolic redox reactions (e.g., lactate dehydrogenase)
  • NADPH: primarily for reductive biosynthesis and antioxidant defense

Clinical tie-in:

  • RBCs use NADH for methemoglobin reductase (reducing Fe³⁺ → Fe²⁺), but the classic Heinz bodies/bite cells after oxidant drug pattern is NADPH/G6PD.

C. ATP in mitochondria via oxidative phosphorylation

Why it’s tempting: Hemolysis → anemia → fatigue → maybe an “energy” issue?

Why it’s wrong: Mature RBCs have no mitochondria, so oxidative phosphorylation is irrelevant.

What RBCs do use:

  • Anaerobic glycolysis for ATP
  • PPP for NADPH
  • 2,3-BPG shunt (Rapoport–Luebering) to regulate oxygen delivery (at the cost of ATP)

If a question wants you to think “RBC energy failure,” it’ll usually push you toward glycolytic enzyme deficiencies (e.g., pyruvate kinase deficiency → echinocytes/burr cells), not mitochondrial ATP.


D. Ribose-5-phosphate in the nucleus

Why it’s tempting: PPP also makes ribose-5-phosphate for nucleotide synthesis.

Why it’s wrong (two reasons):

  1. The immediate problem in the vignette is oxidative hemolysis, not impaired nucleotide synthesis. RBCs are enucleated and don’t synthesize DNA/RNA.
  2. Ribose-5-phosphate is made in the cytosol, not “in the nucleus.”

When ribose-5-phosphate matters clinically:

  • Rapidly dividing tissues (bone marrow, tumors) need ribose for nucleotides.
  • But G6PD deficiency presentations are about hemolysis under oxidative stress.

E. UDP-glucuronic acid in hepatocytes

Why it’s tempting: Jaundice is in the stem—so you might think conjugation defect.

Why it’s wrong: The jaundice here is hemolytic (prehepatic): increased breakdown of heme → ↑ unconjugated (indirect) bilirubin. Hepatic conjugation can be totally normal and still be overwhelmed.

What UDP-glucuronic acid is actually about:

  • Made from UDP-glucose (via UDP-glucose dehydrogenase)
  • Used by UDP-glucuronosyltransferase (UGT) for conjugation of bilirubin and drugs

This distractor is testing whether you can distinguish:

  • Hemolytic jaundice (↑ indirect bilirubin, no primary conjugation failure) vs
  • Conjugation defects (e.g., Gilbert, Crigler-Najjar) which cause unconjugated hyperbilirubinemia without hemolysis signs like Heinz bodies/bite cells

High-Yield “PPP = NADPH” Uses They Love to Test

NADPH is required for:

  • Maintaining reduced glutathione (GSH) in RBCs → protects against oxidative stress
  • Respiratory burst in neutrophils (NADPH oxidase)
    • Defect → chronic granulomatous disease
  • Reductive biosynthesis
    • Fatty acid synthesis
    • Cholesterol/steroid synthesis
  • Cytochrome P450 reactions (drug metabolism)
  • Nitric oxide synthase (NO production)

Tissues with high PPP activity (high-yield list)

  • RBCs
  • Liver
  • Adrenal cortex
  • Gonads
  • Lactating mammary gland
  • Phagocytes (for respiratory burst)

Micro-Table: Nail the Common “Confusable” Associations

Pathway/ProcessMain ProductKey UseClassic Board Tie-In
PPP (oxidative)NADPHAntioxidant defense, reductive synthesisG6PD deficiency → Heinz bodies, bite cells
GlycolysisATP, NADHEnergyPyruvate kinase deficiency → hemolytic anemia, ↑ 2,3-BPG
OxPhos (mitochondria)ATPEnergyNot in RBCs
UGT conjugationConjugated bilirubinBilirubin/drug metabolismGilbert, Crigler-Najjar, neonatal jaundice
Nucleotide synthesisRibose-5-PDNA/RNA precursorsRapidly dividing cells, chemo targets

Exam-Day Takeaways (What to Remember Under Time Pressure)

  • Oxidant stress + hemolysis + bite cells/Heinz bodies = G6PD deficiency
  • The PPP’s “money molecule” in this context is NADPH
  • RBCs have no mitochondria → ignore oxidative phosphorylation choices
  • Jaundice in hemolysis is usually indirect bilirubin from increased heme breakdown, not a primary conjugation defect